AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • September 7th, 2017 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This AMENDMENT TO CONSULTING AGREEMENT (this “Amendment”) is effective as of June 1, 2017 by and between Pluristem Ltd., a company incorporated under the laws of the State of Israel (the “Company”) and Rose High Tech Ltd., a company incorporated under the laws of the State of Israel (the “Consultant). Each of the Company and the Consultant shall be referred to collectively as the “Parties” and individually as a “Party.”
Re: Extension of Term Sheet PeriodTerm Sheet Extension • September 7th, 2017 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
Reference is hereby made to a certain Term Sheet dated December 19, 2016, by and between Pluristem Ltd. and Sosei Corporate Venture Capital Ltd. (the “Term Sheet”).
